PREMIXED INSULIN REGIMEN TO BASAL-BOLUS INSULIN OUTCOMES IN TYPE 2 DIABETES SUBJECTS. Int. Res. J. Pharm. 2023, 14 (2), 40-48. https://doi.org/10.56802/enp5vh61.